TNXP Новости Форекс
Tonix Pharma Granted Up To $34 Mln 5-year DoD Contract For Antiviral Program Development
Tonix Pharmaceuticals Holding Corp. (TNXP) announced Monday it has been awarded an Other Transaction Agreement (OTA) with a potential for up to $34 million over five years by the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense (DoD).
RTTNews
|
123 дней спустя
Tonix Pharma Granted U.S. Patent Covering TNX-1900 For Treatment Of Pain
Biopharmaceutical company Tonix Pharmaceuticals Holding Corp. (TNXP) announced Monday that the United States Patent and Trademark Office (USPTO) issued U.S. Patent 11,389,473 to the Company on July 19, 2022.
RTTNews
|
823 дней спустя
